DK0856312T3 - Anvendelse af trospiumchlorid til fremstilling af et lægemiddel til behandling af blæresygdomme - Google Patents

Anvendelse af trospiumchlorid til fremstilling af et lægemiddel til behandling af blæresygdomme

Info

Publication number
DK0856312T3
DK0856312T3 DK96118939T DK96118939T DK0856312T3 DK 0856312 T3 DK0856312 T3 DK 0856312T3 DK 96118939 T DK96118939 T DK 96118939T DK 96118939 T DK96118939 T DK 96118939T DK 0856312 T3 DK0856312 T3 DK 0856312T3
Authority
DK
Denmark
Prior art keywords
treatment
medicament
trospium chloride
manufacture
bladder
Prior art date
Application number
DK96118939T
Other languages
Danish (da)
English (en)
Inventor
Ulrich Dr Rer Nat Schwantes
Albert Schaupp
Manfred Dr Med Habil Stoehrer
Original Assignee
Pfleger R Chem Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8223435&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0856312(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfleger R Chem Fab filed Critical Pfleger R Chem Fab
Application granted granted Critical
Publication of DK0856312T3 publication Critical patent/DK0856312T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK96118939T 1996-11-27 1996-11-27 Anvendelse af trospiumchlorid til fremstilling af et lægemiddel til behandling af blæresygdomme DK0856312T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP96118939A EP0856312B1 (fr) 1996-11-27 1996-11-27 Utilisation du chlorure de trospium pour la fabrication d'un médicament pour le traitement de maladies de la vessie

Publications (1)

Publication Number Publication Date
DK0856312T3 true DK0856312T3 (da) 1999-06-23

Family

ID=8223435

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96118939T DK0856312T3 (da) 1996-11-27 1996-11-27 Anvendelse af trospiumchlorid til fremstilling af et lægemiddel til behandling af blæresygdomme

Country Status (8)

Country Link
US (1) US5998430A (fr)
EP (1) EP0856312B1 (fr)
JP (1) JPH10158169A (fr)
AT (1) ATE172117T1 (fr)
CA (1) CA2221900C (fr)
DE (1) DE59600683D1 (fr)
DK (1) DK0856312T3 (fr)
ES (1) ES2125696T3 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2246485T3 (es) 1999-07-01 2006-02-16 PHARMACIA & UPJOHN COMPANY LLC (s,s)-reboxetina para tratar la incontinencia.
US6974820B2 (en) * 2002-11-06 2005-12-13 Bridge Pharma, Inc. Methods for treating urinary incontinence and other disorders using trospium
US7056916B2 (en) * 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
US20050009862A1 (en) * 2003-04-25 2005-01-13 Sabounjian Luann Method for promoting uninterrupted sleep by administration of trospium chloride
JP5610663B2 (ja) * 2003-11-04 2014-10-22 スパーナス ファーマシューティカルズ インコーポレイテッド トロスピウムの１日１回剤形
US8709476B2 (en) 2003-11-04 2014-04-29 Supernus Pharmaceuticals, Inc. Compositions of quaternary ammonium compounds containing bioavailability enhancers
US20050255050A1 (en) * 2004-05-14 2005-11-17 Boehringer Ingelheim International Gmbh Powder formulations for inhalation, comprising enantiomerically pure beta agonists
US7220742B2 (en) 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
ES2322148T3 (es) * 2004-08-11 2009-06-17 BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG Medicamentos que contienen anticolinergicos para el tratamiento en las vias urinarias.
US20060287347A1 (en) * 2005-06-21 2006-12-21 Aberg A K G Methods for treating smooth muscle disorders using trospium
US7390816B2 (en) * 2005-06-21 2008-06-24 Bridge Pharma, Inc. Methods for treating urinary incontinence in patients suffering from memory disorders
US20070004766A1 (en) * 2005-07-01 2007-01-04 Aberg A K G Methods for relaxation of smooth muscle contractions using Trospium
CN101208316B (zh) * 2005-08-15 2012-05-09 贝林格尔·英格海姆国际有限公司 制备β-模拟物的方法
WO2008019070A2 (fr) * 2006-08-04 2008-02-14 Ebrahim Versi Compositions pharmaceutiques de trospium pour le traitement de troubles d'hyperactivité de muscle lisse
BR112015005351A2 (pt) * 2012-09-18 2017-07-04 Taris Biomedical Llc sistemas para distribuição de drogas e métodos para tratamento de disfunção de esvaziamento da bexiga e outros distúrbios do trato urinário inferior
BR112021001337A2 (pt) * 2018-08-01 2021-04-20 Taris Biomedical Llc métodos de tratamento de bexiga hiperativa usando tróspio
WO2021198777A1 (fr) 2020-03-30 2021-10-07 Trizell Ltd. Compositions et méthodes pour traiter le cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1194422B (de) 1963-03-05 1965-06-10 Robert Pfleger Chem Fab Dr Verfahren zur Herstellung von Azoniaspironortropanderivaten
DE3546165A1 (de) * 1985-12-27 1987-10-15 Madaus & Co Dr Verwendung von azoniaspironortropanolestern als asthmatherapeutikum und als broncholytikum

Also Published As

Publication number Publication date
US5998430A (en) 1999-12-07
ATE172117T1 (de) 1998-10-15
EP0856312B1 (fr) 1998-10-14
EP0856312A1 (fr) 1998-08-05
DE59600683D1 (de) 1998-11-19
CA2221900C (fr) 2007-10-23
CA2221900A1 (fr) 1998-05-27
JPH10158169A (ja) 1998-06-16
ES2125696T3 (es) 1999-03-01

Similar Documents

Publication Publication Date Title
DK0856312T3 (da) Anvendelse af trospiumchlorid til fremstilling af et lægemiddel til behandling af blæresygdomme
UA41989C2 (uk) Фармацевтична композиція у вигляді гелю для лікування захворювань шкіри та спосіб лікування інфікованої шкіри
SE9404196D0 (sv) New antithrombotic formulation
ATE237330T1 (de) Verabreichung von nikotin im dickdarm zur behandlung von entzündlicher eingeweidenerkrankung
EA200001044A2 (ru) Соединения для лечения женской сексуальной дисфункции
PT1079806E (pt) Preparacoes para a aplicacao de anti-inflamatorios, especialmente, agentes anti-septicos e/ou agentes de promocao da cura de feridas, no tracto respiratorio superior e/ou no ouvido
TR199801180T2 (xx) Aneljestik etkiye sahip yeni bile�ikler.
TNSN94035A1 (fr) Composition veterinaire
HUT76258A (en) Compositions comprising dna damaging agents and p53, and methods for uses thereof
GEP20043269B (en) Purine Derivatives, Method for Their Production and Composition Containing the Same
SE8903914D0 (sv) Oral composition for the treatment of inflammatory bowel diseases
DE69613840D1 (de) Orale dosierungsform und verfahren zur behandlung von schmerzzuständen in dermundhöhle
MXPA02012075A (es) Composicion para mediar el dolor y aparato y metodo para utilizarla.
HUP0202776A2 (hu) (+)-Tramadol, O-demetil-tramadol, (+)-O-demetil-tramadol, O-demetil-N-mono-demetil-tramadol, illetve (+)-O-demetil-N-mono-demetil-tramadol felhasználása vizeletinkontinencia kezelésére alkalmas gyógyszerkészítmény előállítására
AU3324100A (en) Use of pirenoxine for the protection of corneal tissues in photokeratectomy
DE69834724D1 (de) Behandlung von Darm- oder Blasenentzündungen
EP0848948A4 (fr) Composition pour administration rectale a action de longue duree
PT941110E (pt) Utilizacao do factor 2 de crescimento dos ceratinocitos
SE9602644D0 (sv) New use
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
DK1251850T3 (da) Anvendelse af et kombinationspræparat i cancerbehandling
HUP9903679A2 (hu) Olanzapin alkalmazása bipoláris zavar kezelésére szolgáló gyógyszerkészítmények előállítására
BR9603454A (pt) Composição e método para tratamento de câncer de próstata
BR0014751A (pt) Composto, estereoisÈmero ou mistura de estereoisÈmeros, composição farmacêutica, método de tratamento de um paciente em necessidade de tratamento antimicrobiano, e, uso de um composto
MXPA01006011A (es) Composicion para tratamiento de quemaduras.